Q1 2024 Earnings Call Transcript May 1, 2024 Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is $0.59, ...
Good afternoon, everyone. I'm the operator for today's call. Thank you for joining today as Emergent discusses their ...
A one-fifth dose of Bavarian Nordic’s mpox vaccine Jynneos can elicit a similar antibody response as its standard-dose regimen, according to findings presented Saturday at the European Society of ...
"Global Virus-Like Particle Vaccine Market- (By Application Type (Infectious Diseases, Cancer Immunotherapy, Others), By Stage (Pre-clinical Research Stage, Approved Vaccines), By Distribution Channel ...
Vaccines Market in terms of revenue was estimated to be worth $78.0 billion in 2024 and is poised to reach $94.9 billion by 2029, growing at a CAGR of ...
Global Markets for Vaccine Technologies' examines how vaccines are developed, produced, and distributed worldwide, highlighting their pivotal role in ...
Ritchie Torres filed legislation this week aimed at improving the HHS' response to mpox and other health emergencies.
Scientists seem to be close to creating a "one-and-done" vaccine that can protect against any strain of a virus with just one shot. In a press release from the University of California ...
Pharmacists said at the time they were overburdened with prescription and vaccination expectations, especially amid COVID-19 vaccine demand last fall. In other areas of the country, some ...
Nokia said the first quarter marked the low point in mobile networks demand, with activity expected to progressively pick up through the remainder of 2024. The Finnish telecommunications company ...
Recently, Africa received disenchanting news about Moderna's decision to halt the well-thought-out plan to have a vaccine manufacturing ... post-pandemic decrease in demand for Africa's Covid ...
In Brazil, researchers at the University of São Paulo (USP) and the Pernambuco division of Oswaldo Cruz Foundation (FIOCRUZ) are developing a Zika vaccine. The formulation was tested on mice and ...